Los Angeles is famous for the always captivating entertainment industry, some of the most famous sports teams, and incredibly expensive smoothies. But beneath the glamour, it's also a breeding ground for bizarre, historic, and unforgettable crimes. My name is Madison McGee. You might know me from my podcast Ice Cold Case, where for the last three years I've been investigating my father's murder.

But now I've embedded myself into the LA Times crime beat to bring you not only some of the juiciest cases, but what it takes to be a gritty crime reporter in a giant metropolis.

From LA Times Studios comes its latest series, LA Crimes.

From deep dives into the Menendez brothers to conversations about why Bravo TV seems to be a hotbed

of white-collar criminals will cover it all.

The solved, the unsolved, the love triangle's gone wrong.

You get the idea.

Tune in every Wednesday starting May 21st, wherever you stream your podcasts.

You can also watch the episodes on YouTube and Spotify.

You don't want to miss this.

Welcome back to Wellness Unmask with Dr. Nicole Sapphire, and this is your weekly rundown for this

week. A lot of big things happening at the FDA with new FDA Commissioner, Dr. Marty McCarrie.

And one of the big things to come out of the

FDA this week is a new FDA-approved blood test for the early detection of Alzheimer's. Now, this test was

actually able to be expedited in its approval because it is similar to an existing blood test on the market.

But what is different with this blood test is it's looking at the ratio between

the amyloid and the tau proteins. And this plasma ratio test is designed for the early detection

of amyloid plaques that are associated with Alzheimer's disease. The existing test on the market

is a blood test, but it was also needing to be used in conjunction with more expensive and invasive

methodologies like pet slash CT scans or lumbar punctures to look at spinal fluid. This blood test

is designed to be a standalone test. So if it is positive, the assumption can be that the patient

has Alzheimer's disease. Now, this is not being recommended as a screening

...